The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo

R. Clarke, N. Brunner, D. Katz, P. Glanz, R. B. Dickson, Marc E Lippman, F. G. Kern

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

It has been suggested that transforming growth factor-α (TGF-α) is a mitogenic autocrine growth factor for human breast cancer cells, responsible for mediating the mitogenic effects of 17β-estradiol (E2) in responsive cells. To test this hypothesis we have introduced eukaryotic expression vectors directing the expression of TGF-α mRNA into E2-responsive MCF-7 human breast cancer cells. Transfected cells produce levels of TGF-α equivalent to or greater than those produced by both E2-stimulated MCF-7 cells and hormone-independent MDA-MB-231 cells. One transfected clone (H8) secretes sufficient TGF-α to fully down-regulate EGF-R expression. However, both the transfected clones that constitutively secrete elevated levels of TGF-α (A8 and H8) respond to E2 stimulation in vitro by increasing the rate of cellular proliferation and inducing PGR synthesis. The basal proliferative capacity of H8 and A8 cells is equivalent to that of the parental cells and to cells transfected only with the G418 (neomycin) resistance gene. Furthermore, the TGF-α cDNA-transfected clones do not form tumors in ovariectomized athymic nude mice without E2 supplementation. Thus, the precise role of TGF-α in mediating either the in vivo or the in vitro mitogenic effects of E2 in MCF-7 human breast cancer cells remains unclear. While TGF-α expression may be essential it is not sufficient alone to induce the fully E2-independent phenotype. Thus, TGF-α may function in combination with other E2-induced growth factors to control breast cancer proliferation and tumorigenesis.

Original languageEnglish
Pages (from-to)372-380
Number of pages9
JournalMolecular Endocrinology
Volume3
Issue number2
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Transforming Growth Factors
Breast Neoplasms
Growth
Clone Cells
Nude Mice
Intercellular Signaling Peptides and Proteins
In Vitro Techniques
Neomycin
MCF-7 Cells
Epidermal Growth Factor
Estradiol
Carcinogenesis
Down-Regulation
Complementary DNA
Cell Proliferation
Hormones
Phenotype
Messenger RNA

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism

Cite this

Clarke, R., Brunner, N., Katz, D., Glanz, P., Dickson, R. B., Lippman, M. E., & Kern, F. G. (1989). The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo. Molecular Endocrinology, 3(2), 372-380.

The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo. / Clarke, R.; Brunner, N.; Katz, D.; Glanz, P.; Dickson, R. B.; Lippman, Marc E; Kern, F. G.

In: Molecular Endocrinology, Vol. 3, No. 2, 01.01.1989, p. 372-380.

Research output: Contribution to journalArticle

Clarke, R, Brunner, N, Katz, D, Glanz, P, Dickson, RB, Lippman, ME & Kern, FG 1989, 'The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo', Molecular Endocrinology, vol. 3, no. 2, pp. 372-380.
Clarke, R. ; Brunner, N. ; Katz, D. ; Glanz, P. ; Dickson, R. B. ; Lippman, Marc E ; Kern, F. G. / The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo. In: Molecular Endocrinology. 1989 ; Vol. 3, No. 2. pp. 372-380.
@article{4c9028328aed4b74ad7bd534abe78090,
title = "The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo",
abstract = "It has been suggested that transforming growth factor-α (TGF-α) is a mitogenic autocrine growth factor for human breast cancer cells, responsible for mediating the mitogenic effects of 17β-estradiol (E2) in responsive cells. To test this hypothesis we have introduced eukaryotic expression vectors directing the expression of TGF-α mRNA into E2-responsive MCF-7 human breast cancer cells. Transfected cells produce levels of TGF-α equivalent to or greater than those produced by both E2-stimulated MCF-7 cells and hormone-independent MDA-MB-231 cells. One transfected clone (H8) secretes sufficient TGF-α to fully down-regulate EGF-R expression. However, both the transfected clones that constitutively secrete elevated levels of TGF-α (A8 and H8) respond to E2 stimulation in vitro by increasing the rate of cellular proliferation and inducing PGR synthesis. The basal proliferative capacity of H8 and A8 cells is equivalent to that of the parental cells and to cells transfected only with the G418 (neomycin) resistance gene. Furthermore, the TGF-α cDNA-transfected clones do not form tumors in ovariectomized athymic nude mice without E2 supplementation. Thus, the precise role of TGF-α in mediating either the in vivo or the in vitro mitogenic effects of E2 in MCF-7 human breast cancer cells remains unclear. While TGF-α expression may be essential it is not sufficient alone to induce the fully E2-independent phenotype. Thus, TGF-α may function in combination with other E2-induced growth factors to control breast cancer proliferation and tumorigenesis.",
author = "R. Clarke and N. Brunner and D. Katz and P. Glanz and Dickson, {R. B.} and Lippman, {Marc E} and Kern, {F. G.}",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "3",
pages = "372--380",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo

AU - Clarke, R.

AU - Brunner, N.

AU - Katz, D.

AU - Glanz, P.

AU - Dickson, R. B.

AU - Lippman, Marc E

AU - Kern, F. G.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - It has been suggested that transforming growth factor-α (TGF-α) is a mitogenic autocrine growth factor for human breast cancer cells, responsible for mediating the mitogenic effects of 17β-estradiol (E2) in responsive cells. To test this hypothesis we have introduced eukaryotic expression vectors directing the expression of TGF-α mRNA into E2-responsive MCF-7 human breast cancer cells. Transfected cells produce levels of TGF-α equivalent to or greater than those produced by both E2-stimulated MCF-7 cells and hormone-independent MDA-MB-231 cells. One transfected clone (H8) secretes sufficient TGF-α to fully down-regulate EGF-R expression. However, both the transfected clones that constitutively secrete elevated levels of TGF-α (A8 and H8) respond to E2 stimulation in vitro by increasing the rate of cellular proliferation and inducing PGR synthesis. The basal proliferative capacity of H8 and A8 cells is equivalent to that of the parental cells and to cells transfected only with the G418 (neomycin) resistance gene. Furthermore, the TGF-α cDNA-transfected clones do not form tumors in ovariectomized athymic nude mice without E2 supplementation. Thus, the precise role of TGF-α in mediating either the in vivo or the in vitro mitogenic effects of E2 in MCF-7 human breast cancer cells remains unclear. While TGF-α expression may be essential it is not sufficient alone to induce the fully E2-independent phenotype. Thus, TGF-α may function in combination with other E2-induced growth factors to control breast cancer proliferation and tumorigenesis.

AB - It has been suggested that transforming growth factor-α (TGF-α) is a mitogenic autocrine growth factor for human breast cancer cells, responsible for mediating the mitogenic effects of 17β-estradiol (E2) in responsive cells. To test this hypothesis we have introduced eukaryotic expression vectors directing the expression of TGF-α mRNA into E2-responsive MCF-7 human breast cancer cells. Transfected cells produce levels of TGF-α equivalent to or greater than those produced by both E2-stimulated MCF-7 cells and hormone-independent MDA-MB-231 cells. One transfected clone (H8) secretes sufficient TGF-α to fully down-regulate EGF-R expression. However, both the transfected clones that constitutively secrete elevated levels of TGF-α (A8 and H8) respond to E2 stimulation in vitro by increasing the rate of cellular proliferation and inducing PGR synthesis. The basal proliferative capacity of H8 and A8 cells is equivalent to that of the parental cells and to cells transfected only with the G418 (neomycin) resistance gene. Furthermore, the TGF-α cDNA-transfected clones do not form tumors in ovariectomized athymic nude mice without E2 supplementation. Thus, the precise role of TGF-α in mediating either the in vivo or the in vitro mitogenic effects of E2 in MCF-7 human breast cancer cells remains unclear. While TGF-α expression may be essential it is not sufficient alone to induce the fully E2-independent phenotype. Thus, TGF-α may function in combination with other E2-induced growth factors to control breast cancer proliferation and tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=0024516490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024516490&partnerID=8YFLogxK

M3 - Article

C2 - 2710138

AN - SCOPUS:0024516490

VL - 3

SP - 372

EP - 380

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 2

ER -